Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT00491556
What this trial is testing

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 102
Post-approval studies (Phase 4)Study completedNCT00224445
What this trial is testing

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Who this might be right for
HIV Infections
Gilead Sciences 100
Not applicableStudy completedNCT00490412
What this trial is testing

Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 207
Large-scale testing (Phase 3)Study completedNCT00573001
What this trial is testing

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 120
Large-scale testing (Phase 3)Study completedNCT00352053
What this trial is testing

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 87
Not applicableUnknownNCT04878601
What this trial is testing

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 470
Not applicableStudy completedNCT00575939
What this trial is testing

Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV

Who this might be right for
HIV InfectionsAtherosclerosis
University Hospitals Cleveland Medical Center 120
Post-approval studies (Phase 4)UnknownNCT04910711
What this trial is testing

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV

Who this might be right for
Human Immunodeficiency VirusContraceptionART
Botswana Harvard AIDS Institute Partnership 140
Not applicableStudy completedNCT01191281
What this trial is testing

Improving Food Security and Nutrition to Promote ART Adherence in Latin America

Who this might be right for
Medication Adherence
RAND 400
Early research (Phase 1)Study completedNCT00697892
What this trial is testing

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Who this might be right for
HIV InfectionsMalaria
Fran Aweeka 38
Post-approval studies (Phase 4)Study completedNCT00677300
What this trial is testing

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients

Who this might be right for
HIV Infections
Dallas VA Medical Center 85
Post-approval studies (Phase 4)Study completedNCT02945163
What this trial is testing

Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy

Who this might be right for
HIV Infections
Shanghai Public Health Clinical Center 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT06497504
What this trial is testing

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

Who this might be right for
Hepatitis B
GlaxoSmithKline 153
Not applicableStudy completedNCT01317498
What this trial is testing

The VMVN Study: Virological Monitoring in Viet Nam

Who this might be right for
HIV InfectionAIDS
Beth Israel Deaconess Medical Center 650
Testing effectiveness (Phase 2)Temporarily pausedNCT00004998
What this trial is testing

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 30
Not applicableStudy completedNCT00000914
What this trial is testing

The Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 800
Not applicableWithdrawnNCT03928834
What this trial is testing

Sustainable Adherence and Prevention of HIV Drug Resistance in Adolescents

Who this might be right for
Medication AdherenceHIV Drug Resistance
University of Zimbabwe
Large-scale testing (Phase 3)Study completedNCT02105987
What this trial is testing

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 555
Early research (Phase 1)Study completedNCT02511990
What this trial is testing

The Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

Who this might be right for
HealthyHIV
Rockefeller University 33
Testing effectiveness (Phase 2)Ended earlyNCT00783614
What this trial is testing

Aspirin and Antiretroviral Therapy in HIV Infected Patients

Who this might be right for
HIV Infection
Hennepin Healthcare Research Institute 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation